Dual gut hormone receptor agonists for diabetes and obesity

J Clin Invest. 2023 Feb 1;133(3):e167952. doi: 10.1172/JCI167952.

Authors

Joseph Bass¹, Matthias H Tschöp^{2

3}, Lisa R Beutler¹

Affiliations

¹ Northwestern University Feinberg School of Medicine, Department of Medicine, Division of Endocrinology, Metabolism and Molecular Medicine, Chicago, Illinois, USA.
² Helmholtz Munich, Neuherberg, Germany.
³ Technische Universität München, Munich, Germany.

No abstract available

MeSH terms

Diabetes Mellitus, Type 2* / drug therapy
Glucagon-Like Peptide-1 Receptor Agonists
Hormones
Humans
Obesity* / drug therapy

Substances

Hormones
Glucagon-Like Peptide-1 Receptor Agonists

Grants and funding